Establishment Labs (ESTA) | Stock Overview & Key Data
Establishment Labs Performance Comparison
Stock Range
Today's Range
Low: $38.50
High: $41.82
on October 6, 2025
52 Week Range
Low: $26.56
High: $50.85
on April 9, 2025
on November 7, 2024
All-Time High: $93.80 on April 18, 2022
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$1.2B
EPS
-3.08
P/E Ratio (TTM)
-13.81
Forward P/E
-25.11
P/B Ratio
52.71
PEG Ratio
1.71
Div. Yield
N/A
ROE
-261.18%
Beta
0.856
Debt to Equity
993.34
Financial Highlights
Profitability
Gross Margin
68.76%
Operating Margin
-27.50%
Profit Margin
-49.89%
Returns and Earnings
Return on Assets (TTM)
-12.78%
Return on Equity (TTM)
-261.18%
EBITDA
$-54.0M
Net Income (TTM)
$-88.5M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$6.16
Quarterly Revenue Growth (YoY)
16.30%
Quarterly Earnings Growth (YoY)
16.28%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Establishment Labs ESTA | 1.20B Small-cap | -4.93% | 2.85% | -14.70% | 25.65% | -13.14% | -1.26% | -29.48% | 115.51% |
| Abbott Laboratories ABT | 234.39B Mega-cap | 0.47% | 1.16% | 0.03% | 7.11% | 17.89% | 15.17% | 32.53% | 21.95% |
| Boston Scientific BSX | 144.20B Large-cap | -0.35% | -10.58% | -6.87% | 5.64% | 8.19% | 11.02% | 141.87% | 151.56% |
| Artivion AORT | 1.98B Small-cap | -3.07% | -6.19% | 34.53% | 76.48% | 45.12% | 57.21% | 291.07% | 112.02% |
| Enovis ENOV | 1.83B Small-cap | 3.58% | -0.45% | -5.33% | -3.82% | -29.44% | -22.28% | -30.50% | -42.68% |
| Novocure NVCR | 1.64B Small-cap | 12.23% | 15.08% | -14.15% | -12.70% | -51.65% | -7.94% | -80.17% | -89.41% |
Ownership & Short Interest
Insider Ownership
10.75%
Institutional Ownership
107.79%
Shares Short
5M
Short Ratio
18.92
Short % of Shares Outstanding
25.89%
Average 10-Day Volume
313K
Average 90-Day Volume
267K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ESTA's 52-week high and low?
- In the last 52 weeks, Establishment Labs reached a high of $50.85 (on November 7, 2024) and a low of $26.56 (on April 9, 2025).
- What is the market cap and P/E ratio for ESTA?
- Curious about Establishment Labs's size and valuation? Its market capitalization stands at 1.20B. When it comes to valuation, the P/E ratio (trailing twelve months) is -13.81, and the forward P/E (looking ahead) is -25.11.
- Does ESTA pay dividends? If so, what's the yield?
- As for dividends, Establishment Labs isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Establishment Labs's main competitors or similar companies to consider before investing?
When looking at Establishment Labs, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT234.39B Healthcare Medical Devices 15.17% 32.53% Boston Scientific
BSX144.20B Healthcare Medical Devices 11.02% 141.87% Artivion
AORT1.98B Healthcare Medical Devices 57.21% 291.07% Enovis
ENOV1.83B Healthcare Medical Devices -22.28% -30.50% Novocure
NVCR1.64B Healthcare Medical Devices -7.94% -80.17% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Establishment Labs Holdings Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Establishment Labs's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -261.18%, the Debt to Equity ratio from the most recent quarter is 993.34, and its Gross Profit Margin stands at 68.76%.
- What is the recent revenue and earnings growth for ESTA?
- Looking at Establishment Labs's growth, its revenue over the trailing twelve months (TTM) was $177M. Compared to the same quarter last year (YoY), quarterly revenue grew by 16.30%, and quarterly earnings saw a YoY growth of 16.28%.
- How much of ESTA stock is held by insiders and institutions?
- Wondering who owns Establishment Labs stock? Company insiders (like executives and directors) hold about 10.75% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 107.79%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.